Margaret Sunitha Selvaraj1,2,3, Kaavya Paruchuri1,2, Sara Haidermota1,2, Rachel Bernardo1,2, Stephen S Rich4, Gina M Peloso5, Pradeep Natarajan1,2,3. 1. Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, United States of America. 2. Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, United States of America. 3. Department of Medicine, Harvard Medical School, Boston, MA, United States of America. 4. Center for Public Health Genomics, University of Virginia, Charlottesville, VA, United States of America. 5. Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America.
Abstract
PURPOSE: We aimed to discover loci associated with triglyceride (TG) levels in the context of type 2 diabetes (T2D). We conducted a genome-wide association study (GWAS) in 424,120 genotyped participants of the UK Biobank (UKB) with T2D status and TG levels. METHODS: We stratified the cohort based on T2D status and conducted association analyses of TG levels for genetic variants with minor allele count (MAC) at least 20 in each stratum. Effect differences of genetic variants by T2D status were determined by Cochran's Q-test and we validated the significantly associated variants in the Mass General Brigham Biobank (MGBB). RESULTS: Among 21,176 T2D and 402,944 non-T2D samples from UKB, stratified GWAS identified 19 and 315 genomic risk loci significantly associated with TG levels, respectively. Only chr6p21.32 exhibited genome-wide significant heterogeneity (I2 = 98.4%; pheterogeneity = 2.1x10-15), with log(TG) effect estimates of -0.066 (95%CI: -0.082, -0.050) and 0.002 (95%CI: -0.002, 0.006) for T2D and non-T2D, respectively. The lead variant rs9274619:A (allele frequency 0.095) is located 2Kb upstream of the HLA-DQB1 gene, between HLA-DQB1 and HLA-DQA2 genes. We replicated this finding among 25,137 participants (6,951 T2D cases) of MGBB (pheterogeneity = 9.5x10-3). Phenome-wide interaction association analyses showed that the lead variant was strongly associated with a concomitant diagnosis of type 1 diabetes (T1D) as well as diabetes-associated complications. CONCLUSION: In conclusion, we identified an intergenic variant near HLA-DQB1/DQA2 significantly associates with decreased triglycerides only among those with T2D and highlights an immune overlap with T1D.
PURPOSE: We aimed to discover loci associated with triglyceride (TG) levels in the context of type 2 diabetes (T2D). We conducted a genome-wide association study (GWAS) in 424,120 genotyped participants of the UK Biobank (UKB) with T2D status and TG levels. METHODS: We stratified the cohort based on T2D status and conducted association analyses of TG levels for genetic variants with minor allele count (MAC) at least 20 in each stratum. Effect differences of genetic variants by T2D status were determined by Cochran's Q-test and we validated the significantly associated variants in the Mass General Brigham Biobank (MGBB). RESULTS: Among 21,176 T2D and 402,944 non-T2D samples from UKB, stratified GWAS identified 19 and 315 genomic risk loci significantly associated with TG levels, respectively. Only chr6p21.32 exhibited genome-wide significant heterogeneity (I2 = 98.4%; pheterogeneity = 2.1x10-15), with log(TG) effect estimates of -0.066 (95%CI: -0.082, -0.050) and 0.002 (95%CI: -0.002, 0.006) for T2D and non-T2D, respectively. The lead variant rs9274619:A (allele frequency 0.095) is located 2Kb upstream of the HLA-DQB1 gene, between HLA-DQB1 and HLA-DQA2 genes. We replicated this finding among 25,137 participants (6,951 T2D cases) of MGBB (pheterogeneity = 9.5x10-3). Phenome-wide interaction association analyses showed that the lead variant was strongly associated with a concomitant diagnosis of type 1 diabetes (T1D) as well as diabetes-associated complications. CONCLUSION: In conclusion, we identified an intergenic variant near HLA-DQB1/DQA2 significantly associates with decreased triglycerides only among those with T2D and highlights an immune overlap with T1D.
Authors: Michael Miller; Neil J Stone; Christie Ballantyne; Vera Bittner; Michael H Criqui; Henry N Ginsberg; Anne Carol Goldberg; William James Howard; Marc S Jacobson; Penny M Kris-Etherton; Terry A Lennie; Moshe Levi; Theodore Mazzone; Subramanian Pennathur Journal: Circulation Date: 2011-04-18 Impact factor: 29.690
Authors: Frank M Sacks; Michel P Hermans; Paola Fioretto; Paul Valensi; Timothy Davis; Edward Horton; Christoph Wanner; Khalid Al-Rubeaan; Ronnie Aronson; Isabella Barzon; Louise Bishop; Enzo Bonora; Pongamorn Bunnag; Lee-Ming Chuang; Chaicharn Deerochanawong; Ronald Goldenberg; Benjamin Harshfield; Cristina Hernández; Susan Herzlinger-Botein; Hiroshi Itoh; Weiping Jia; Yi-Der Jiang; Takashi Kadowaki; Nancy Laranjo; Lawrence Leiter; Takashi Miwa; Masato Odawara; Ken Ohashi; Atsushi Ohno; Changyu Pan; Jiemin Pan; Juan Pedro-Botet; Zeljko Reiner; Carlo Maria Rotella; Rafael Simo; Masami Tanaka; Eugenia Tedeschi-Reiner; David Twum-Barima; Giacomo Zoppini; Vincent J Carey Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: Thomas Jacobi; Lucas Massier; Nora Klöting; Katrin Horn; Alexander Schuch; Peter Ahnert; Christoph Engel; Markus Löffler; Ralph Burkhardt; Joachim Thiery; Anke Tönjes; Michael Stumvoll; Matthias Blüher; Ilias Doxiadis; Markus Scholz; Peter Kovacs Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958
Authors: Henry Erlich; Ana Maria Valdes; Janelle Noble; Joyce A Carlson; Mike Varney; Pat Concannon; Josyf C Mychaleckyj; John A Todd; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Priscilla Moonsamy Journal: Diabetes Date: 2008-02-05 Impact factor: 9.461
Authors: Alison K Wright; Evangelos Kontopantelis; Richard Emsley; Iain Buchan; Naveed Sattar; Martin K Rutter; Darren M Ashcroft Journal: Diabetes Care Date: 2016-12-20 Impact factor: 19.112
Authors: Wei-Qi Wei; Lisa A Bastarache; Robert J Carroll; Joy E Marlo; Travis J Osterman; Eric R Gamazon; Nancy J Cox; Dan M Roden; Joshua C Denny Journal: PLoS One Date: 2017-07-07 Impact factor: 3.240
Authors: Patrick Wu; Aliya Gifford; Xiangrui Meng; Xue Li; Harry Campbell; Tim Varley; Juan Zhao; Robert Carroll; Lisa Bastarache; Joshua C Denny; Evropi Theodoratou; Wei-Qi Wei Journal: JMIR Med Inform Date: 2019-11-29